Adjusting FDA policies to address bioterrorist threat
- PMID: 10207870
- DOI: 10.1038/7873
Adjusting FDA policies to address bioterrorist threat
Similar articles
-
Particulate delivery systems for biodefense subunit vaccines.Adv Drug Deliv Rev. 2005 Jun 17;57(9):1247-65. doi: 10.1016/j.addr.2005.01.010. Epub 2005 Apr 18. Adv Drug Deliv Rev. 2005. PMID: 15935873 Review.
-
Immunization against potential biological warfare agents.Clin Infect Dis. 2000 Jun;30(6):843-50. doi: 10.1086/313812. Epub 2000 Jun 20. Clin Infect Dis. 2000. PMID: 10880299 Review.
-
Old legacies and new paradigms: confusing "research" and "treatment" and its consequences in responding to emergent health threats.J Health Care Law Policy. 2005;8(1):38-70. J Health Care Law Policy. 2005. PMID: 16538801 No abstract available.
-
Bioterrorism: a clear and present danger.Nat Med. 2001 Dec;7(12):1271-3. doi: 10.1038/nm1201-1271. Nat Med. 2001. PMID: 11726956 No abstract available.
-
Canada: Soldiers have right to refuse anthrax vaccine.Christ Sci Monitor (East Ed). 2000 May 9;92(17):7. Christ Sci Monitor (East Ed). 2000. PMID: 15586926 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical